PDE4B and chronic obstructive pulmonary disease: For example, in chronic obstructive pulmonary disease, the inhibition of PDE4B may result in a reduction of neutrophilic inflammation and mucus hypersecretion, both of which are characteristic features of the disease (Lim et al., 2021).